SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomm is surging after reporting a strong quarterly beat and announcing a significant move into the data center market, including custom chip shipments to a major hyperscaler. The community is actively debating whether this signals a long-term rerating for the stock as an AI infrastructure player, with many traders discussing bullish momentum, significant buyback news, and the potential for a larger breakout.

Fastly, Inc. provides real-time content delivery network services. It offers edge compute, edge delivery, edge security, edge applications like load balancing and image optimization, video on demand, and managed edge delivery. The company was founded by Artur Bergman, Tyler McMullen, Simon Wistow, and Gil Penchina in March 2011 and is headquartered in San Francisco, CA.

Fastly Inc - Ordinary Shares - Class A

Fastly Inc

Fastly is facing intense market volatility following a sharp post-earnings selloff, as investors weigh the company's strong revenue growth and raised guidance against concerns over deceleration and profit margins. While some traders view the significant price drop as an overreaction that offers a bargain entry point, others are cautious, noting that the company's elevated valuation prior to the report leaves it vulnerable to shifts in institutional sentiment.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology Group is trending as investors react to a significant expansion of its AI infrastructure collaboration in India, fueling community optimism about long-term revenue growth. While some investors are expressing frustration over the lack of updated financial guidance and transparency, many are focused on a potential short squeeze, citing high short interest and a tight trading float as catalysts for a major price move.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is rallying as investors react to the strategic acquisition of Mirantis, which bolsters the company's AI cloud capabilities and provides a crucial software layer for enterprise clients. The community is heavily focused on the potential for imminent large-scale hyperscaler contracts and positive momentum leading into earnings, driving significant interest from both institutional and retail traders.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is experiencing intense community debate as investors navigate a disconnect between the company's strong revenue growth and a persistent stock price slide near 52-week lows. Bulls are actively discussing a potential post-earnings recovery and institutional accumulation, while many are focused on whether the upcoming earnings will justify a valuation shift despite ongoing competition and market volatility.

Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company, which engages in the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases. It also delivers off-the-shelf treatments to patients with high unmet medical need. Its product pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in Thousand Oaks, CA.

Atara Biotherapeutics Inc

Atara Biotherapeutics is trending after receiving FDA guidance that a single-arm study could support a future marketing application for tabelecleucel, signaling a clearer path forward and fueling a sharp, halt-inducing rally. While retail investors are actively debating the potential for a short squeeze and long-term recovery, many are cautioning that the company remains in a financially distressed position and will require significant time to resubmit its application.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is surging as investors react to strong earnings results that highlight improving margins and robust data center demand, effectively challenging the bearish sentiment regarding legal and supply chain issues. The community is actively discussing the potential for a massive short squeeze, with many pointing to the stock's low valuation relative to industry peers and its critical role in AI infrastructure.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is attracting significant attention as investors react to a powerful earnings report that featured substantial revenue and net income growth alongside record-breaking margins. The community is actively debating the stock's future, weighing intense bullish excitement over the company's AI-driven ad engine against skepticism from those wary of short-term volatility and complex market manipulation.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

SPY is trending amid intense market volatility as investors weigh conflicting headlines surrounding a potential Iran peace deal and persistent broader uptrend dynamics. The community remains deeply polarized, with active debates between bears anticipating a technical pullback or crash and bulls aggressively buying intraday dips on the expectation of continued market support.

Amprius Technologies, Inc. engages in the development, manufacture, and market of lithium-ion batteries for mobility applications, including the aviation, electric vehicle and light electric vehicle industries. It operates through the following geographical segments: North America, EMEA, and Asia Pacific. The company was founded by Mark C. Platshon in 2008 and headquartered in Fremont, CA.

Amprius Technologies Inc

Amprius Technologies is facing high volatility as investors weigh the impact of a recent warrant exchange program and dilution concerns against strong revenue growth. The community remains deeply divided, with some traders eyeing the dip as a prime buying opportunity based on long-term growth prospects, while others are closely monitoring price action for signs of a technical base.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

NeuroSense Announces Pricing of Insider-Led PIPE Financing

NeuroSense Announces Pricing of Insider-Led PIPE Financing NeuroSense Announces Pricing of Insider-Led PIPE Financing PR Newswire CAMBRIDGE, Mass., April 28, 2026 Financing led by CEO Alon Ben-Noon...

NeuroSense Granted Brazilian Patent Covering PrimeC Composition

NeuroSense Granted Brazilian Patent Covering PrimeC Composition NeuroSense Granted Brazilian Patent Covering PrimeC Composition PR Newswire CAMBRIDGE, Mass., April 6, 2026 Patent Protection Through...

NeuroSense Therapeutics Announces Receipt of Nasdaq Notifications Regarding Minimum Bid Price and Market Value Requirements

NeuroSense Therapeutics Announces Receipt of Nasdaq Notifications Regarding Minimum Bid Price and Market Value Requirements NeuroSense Therapeutics Announces Receipt of Nasdaq Notifications Regarding...

NeuroSense Therapeutics Reports Year End 2025 Financial Results and Provides Business Update

NeuroSense Therapeutics Reports Year End 2025 Financial Results and Provides Business Update NeuroSense Therapeutics Reports Year End 2025 Financial Results and Provides Business Update PR Newswire...

NeuroSense Advances Toward Key Regulatory Milestones with Strengthened Data Package and Near-Term Alzheimer's Readout

NeuroSense Advances Toward Key Regulatory Milestones with Strengthened Data Package and Near-Term Alzheimer's Readout NeuroSense Advances Toward Key Regulatory Milestones with Strengthened Data...

PrimeC New Data to Be Presented at AD/PD 2026 Conference

PrimeC New Data to Be Presented at AD/PD 2026 Conference PrimeC New Data to Be Presented at AD/PD 2026 Conference PR Newswire CAMBRIDGE, Mass., March 18, 2026 Dr. Christian Lunetta to Present 'From...

JAMA Neurology Publishes Results from PARADIGM Phase 2b Trial of PrimeC in ALS Demonstrating Meaningful Clinical Outcomes and Biological Activity

JAMA Neurology Publishes Results from PARADIGM Phase 2b Trial of PrimeC in ALS Demonstrating Meaningful Clinical Outcomes and Biological Activity JAMA Neurology Publishes Results from PARADIGM Phase...

PrimeC Long-Term Survival Data to Be Presented at a Leading ALS Scientific Conference

PrimeC Long-Term Survival Data to Be Presented at a Leading ALS Scientific Conference PrimeC Long-Term Survival Data to Be Presented at a Leading ALS Scientific Conference PR Newswire CAMBRIDGE...

NeuroSense Announces Statistically Significant 65% Reduction in Risk of Death and Greater than 14-Month Median Survival Benefit with PrimeC in ALS

NeuroSense Announces Statistically Significant 65% Reduction in Risk of Death and Greater than 14-Month Median Survival Benefit with PrimeC in ALS NeuroSense Announces Statistically Significant 65...

NeuroSense Expands Global IP Protection Strategy With Granted Australian Patent Covering PrimeC Composition

NeuroSense Expands Global IP Protection Strategy With Granted Australian Patent Covering PrimeC Composition NeuroSense Expands Global IP Protection Strategy With Granted Australian Patent Covering...

Neurosense Therapeutics Ltd. is a clinical-stage biotechnology company, which engages n the discovery and development of targeted therapeutics for neurodegenerative diseases. The firm offers PrimeC, a therapy for amyotrophic lateral sclerosis (ALS). It also conducts testing of product candidates for the treatment of Parkinson's and Alzheimer's diseases. The company was founded by Alon Ben-Noon on February 13, 2017 and is headquartered in Herzliya, Israel.

Current Price	$0.8948
Prev Close	$0.8979
Open	$0.89
Dividend Yield	0.00%
50-Day Moving Average	$0.7936
Beta	0.76
Avg. Volume	136,083.26
PE Ratio	-1.54

52-Week High	$2.60
52-Week Low	$0.63
Market Capitalization	$31.74M
EPS (Annual)	-$0.4366
Price to Book	8.07
Revenue Per Employee	$0.00

NRSN
NeuroSense Therapeutics Ltd

Feed

News

Sentiment

Fundamentals

Info

Latest NRSN News

NRSNNeuroSense Therapeutics Ltd